215 related articles for article (PubMed ID: 29346763)
1. Derepression of the Iroquois Homeodomain Transcription Factor Gene IRX3 Confers Differentiation Block in Acute Leukemia.
Somerville TDD; Simeoni F; Chadwick JA; Williams EL; Spencer GJ; Boros K; Wirth C; Tholouli E; Byers RJ; Somervaille TCP
Cell Rep; 2018 Jan; 22(3):638-652. PubMed ID: 29346763
[TBL] [Abstract][Full Text] [Related]
2. The Hematopoietic TALE-Code Shows Normal Activity of IRX1 in Myeloid Progenitors and Reveals Ectopic Expression of IRX3 and IRX5 in Acute Myeloid Leukemia.
Nagel S; Pommerenke C; Meyer C; MacLeod RAF
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328612
[TBL] [Abstract][Full Text] [Related]
3. Differentiation block in acute myeloid leukemia regulated by intronic sequences of
Camera F; Romero-Camarero I; Revell BH; Amaral FMR; Sinclair OJ; Simeoni F; Wiseman DH; Stojic L; Somervaille TCP
iScience; 2023 Aug; 26(8):107319. PubMed ID: 37539037
[TBL] [Abstract][Full Text] [Related]
4. Frequent Derepression of the Mesenchymal Transcription Factor Gene FOXC1 in Acute Myeloid Leukemia.
Somerville TD; Wiseman DH; Spencer GJ; Huang X; Lynch JT; Leong HS; Williams EL; Cheesman E; Somervaille TC
Cancer Cell; 2015 Sep; 28(3):329-42. PubMed ID: 26373280
[TBL] [Abstract][Full Text] [Related]
5. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
Jankovic D; Gorello P; Liu T; Ehret S; La Starza R; Desjobert C; Baty F; Brutsche M; Jayaraman PS; Santoro A; Mecucci C; Schwaller J
Blood; 2008 Jun; 111(12):5672-82. PubMed ID: 18388181
[TBL] [Abstract][Full Text] [Related]
6. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
[TBL] [Abstract][Full Text] [Related]
7. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
8. [Expression of HoxA10 in acute leukemia and its significance].
Huang Y; Li WJ; Wei CX; Zhou Z; Nie B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):959-63. PubMed ID: 16403259
[TBL] [Abstract][Full Text] [Related]
9. An induced pluripotent stem cell t(7;12)(q36;p13) acute myeloid leukemia model shows high expression of MNX1 and a block in differentiation of the erythroid and megakaryocytic lineages.
Nilsson T; Waraky A; Östlund A; Li S; Staffas A; Asp J; Fogelstrand L; Abrahamsson J; Palmqvist L
Int J Cancer; 2022 Sep; 151(5):770-782. PubMed ID: 35583991
[TBL] [Abstract][Full Text] [Related]
10. Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.
Kawagoe H; Grosveld GC
Blood; 2005 Dec; 106(13):4269-77. PubMed ID: 16105979
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion.
Thorsteinsdottir U; Mamo A; Kroon E; Jerome L; Bijl J; Lawrence HJ; Humphries K; Sauvageau G
Blood; 2002 Jan; 99(1):121-9. PubMed ID: 11756161
[TBL] [Abstract][Full Text] [Related]
12. Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice.
Nandakumar SK; Johnson K; Throm SL; Pestina TI; Neale G; Persons DA
Exp Hematol; 2015 Jul; 43(7):565-77.e1-10. PubMed ID: 25907033
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expression.
Juul-Dam KL; Shukla NN; Cooper TM; Cuglievan B; Heidenreich O; Kolb EA; Rasouli M; Hasle H; Zwaan CM
Eur J Med Genet; 2023 Dec; 66(12):104869. PubMed ID: 38174649
[TBL] [Abstract][Full Text] [Related]
14. The Role of IRX Homeobox Genes in Hematopoietic Progenitors and Leukemia.
Nagel S
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833225
[TBL] [Abstract][Full Text] [Related]
15. HoxA9 binds and represses the Cebpa +8 kb enhancer.
Peng L; Guo H; Ma P; Sun Y; Dennison L; Aplan PD; Hess JL; Friedman AD
PLoS One; 2019; 14(5):e0217604. PubMed ID: 31120998
[TBL] [Abstract][Full Text] [Related]
16. HOXA9 is required for survival in human MLL-rearranged acute leukemias.
Faber J; Krivtsov AV; Stubbs MC; Wright R; Davis TN; van den Heuvel-Eibrink M; Zwaan CM; Kung AL; Armstrong SA
Blood; 2009 Mar; 113(11):2375-85. PubMed ID: 19056693
[TBL] [Abstract][Full Text] [Related]
17. Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9.
So CW; Karsunky H; Wong P; Weissman IL; Cleary ML
Blood; 2004 Apr; 103(8):3192-9. PubMed ID: 15070702
[TBL] [Abstract][Full Text] [Related]
18. Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia.
Wang H; Lindsey S; Konieczna I; Bei L; Horvath E; Huang W; Saberwal G; Eklund EA
J Biol Chem; 2009 Jan; 284(4):2549-67. PubMed ID: 19022774
[TBL] [Abstract][Full Text] [Related]
19. Pirin downregulation is a feature of AML and leads to impairment of terminal myeloid differentiation.
Licciulli S; Cambiaghi V; Scafetta G; Gruszka AM; Alcalay M
Leukemia; 2010 Feb; 24(2):429-37. PubMed ID: 20010624
[TBL] [Abstract][Full Text] [Related]
20. PBX3 is an important cofactor of HOXA9 in leukemogenesis.
Li Z; Zhang Z; Li Y; Arnovitz S; Chen P; Huang H; Jiang X; Hong GM; Kunjamma RB; Ren H; He C; Wang CZ; Elkahloun AG; Valk PJ; Döhner K; Neilly MB; Bullinger L; Delwel R; Löwenberg B; Liu PP; Morgan R; Rowley JD; Yuan CS; Chen J
Blood; 2013 Feb; 121(8):1422-31. PubMed ID: 23264595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]